Variant report

Variant	nsv9126
Chromosome Location	chr14:24475840-24505714
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr14:24483175-24483522	HepG2	liver:	n/a	n/a
2	ARID3A	chr14:24502290-24502595	HepG2	liver:	n/a	n/a
3	ARID3A	chr14:24483172-24483507	K562	blood:	n/a	n/a
4	BACH1	chr14:24476252-24476312	H1-hESC	embryonic stem cell:	n/a	n/a
5	BCL3	chr14:24502093-24502738	A549	lung:	n/a	n/a
6	BHLHE40	chr14:24483187-24483465	GM12878	blood:	n/a	n/a
7	BHLHE40	chr14:24483227-24483438	K562	blood:	n/a	n/a
8	BHLHE40	chr14:24475943-24476541	HepG2	liver:	n/a	n/a
9	BRCA1	chr14:24483351-24483423	GM12878	blood:	n/a	n/a
10	CBX3	chr14:24483227-24483553	K562	blood:	n/a	n/a
11	CBX3	chr14:24501866-24502194	K562	blood:	n/a	n/a
12	CBX3	chr14:24483218-24483539	K562	blood:	n/a	n/a
13	CBX3	chr14:24501883-24502114	K562	blood:	n/a	n/a
14	CBX3	chr14:24476155-24476416	K562	blood:	n/a	n/a
15	CEBPB	chr14:24502240-24502596	A549	lung:	n/a	chr14:24502436-24502447 chr14:24502436-24502447 chr14:24502434-24502447 chr14:24502434-24502445
16	CEBPB	chr14:24502247-24502669	HepG2	liver:	n/a	chr14:24502436-24502447 chr14:24502436-24502447 chr14:24502434-24502447 chr14:24502434-24502445
17	CEBPB	chr14:24505530-24505585	Hela-S3	cervix:	n/a	n/a
18	CEBPB	chr14:24504202-24504207	Hela-S3	cervix:	n/a	n/a
19	CEBPB	chr14:24502240-24502694	Hela-S3	cervix:	n/a	chr14:24502436-24502447 chr14:24502436-24502447 chr14:24502434-24502447 chr14:24502434-24502445
20	CEBPB	chr14:24503705-24503975	MCF-7	breast:	n/a	n/a
21	CEBPB	chr14:24504095-24504242	HepG2	liver:	n/a	n/a
22	CEBPB	chr14:24502257-24502651	A549	lung:	n/a	chr14:24502436-24502447 chr14:24502436-24502447 chr14:24502434-24502447 chr14:24502434-24502445
23	CEBPB	chr14:24502174-24502650	HepG2	liver:	n/a	chr14:24502436-24502447 chr14:24502436-24502447 chr14:24502434-24502447 chr14:24502434-24502445
24	CEBPB	chr14:24502235-24502633	MCF-7	breast:	n/a	chr14:24502436-24502447 chr14:24502436-24502447 chr14:24502434-24502447 chr14:24502434-24502445
25	CEBPB	chr14:24502095-24502733	A549	lung:	n/a	chr14:24502436-24502447 chr14:24502436-24502447 chr14:24502434-24502447 chr14:24502434-24502445
26	CEBPB	chr14:24503875-24503956	A549	lung:	n/a	n/a
27	CEBPB	chr14:24502254-24502670	IMR90	lung:	n/a	chr14:24502436-24502447 chr14:24502436-24502447 chr14:24502434-24502447 chr14:24502434-24502445
28	CEBPB	chr14:24502325-24502567	HepG2	liver:	n/a	chr14:24502436-24502447 chr14:24502436-24502447 chr14:24502434-24502447 chr14:24502434-24502445
29	CEBPB	chr14:24482978-24483461	A549	lung:	n/a	n/a
30	CEBPB	chr14:24503873-24504233	HepG2	liver:	n/a	n/a
31	CEBPB	chr14:24502288-24502568	K562	blood:	n/a	chr14:24502436-24502447 chr14:24502436-24502447 chr14:24502434-24502447 chr14:24502434-24502445
32	CEBPB	chr14:24503786-24503943	HepG2	liver:	n/a	n/a
33	CEBPB	chr14:24502292-24502624	K562	blood:	n/a	chr14:24502436-24502447 chr14:24502436-24502447 chr14:24502434-24502447 chr14:24502434-24502445
34	CEBPB	chr14:24502259-24502654	HepG2	liver:	n/a	chr14:24502436-24502447 chr14:24502436-24502447 chr14:24502434-24502447 chr14:24502434-24502445
35	CEBPD	chr14:24502317-24502638	HepG2	liver:	n/a	chr14:24502435-24502446
36	CEBPD	chr14:24505308-24505800	HepG2	liver:	n/a	n/a
37	CEBPD	chr14:24475992-24476248	HepG2	liver:	n/a	n/a
38	CEBPD	chr14:24502325-24502575	HepG2	liver:	n/a	chr14:24502435-24502446
39	CHD1	chr14:24483316-24483498	GM12878	blood:	n/a	n/a
40	CHD2	chr14:24483281-24483447	GM12878	blood:	n/a	n/a
41	CHD2	chr14:24505468-24505622	Hela-S3	cervix:	n/a	n/a
42	CHD2	chr14:24502364-24502617	Hela-S3	cervix:	n/a	n/a
43	CREB1	chr14:24502329-24502597	A549	lung:	n/a	n/a
44	CTCF	chr14:24483280-24483456	MCF-7	breast:	n/a	n/a
45	CTCF	chr14:24483260-24483410	Caco-2	colon:	n/a	n/a
46	CTCF	chr14:24503750-24504019	HepG2	liver:	n/a	n/a
47	CTCF	chr14:24483147-24483522	ECC-1	luminal epithelium:	n/a	n/a
48	CTCF	chr14:24483184-24483446	SK-N-SH_RA	brain:	n/a	n/a
49	CTCF	chr14:24489363-24489490	LNCaP	prostate:	n/a	n/a
50	CTCF	chr14:24483213-24483468	LNCaP	prostate:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr14:24476478-24476528	GM19239	blood:	n/a
2	chr14:24476478-24476528	GM19239	blood:	n/a
3	chr14:24505653-24505703	A549	lung:	n/a
4	chr14:24476559-24476609	HNPCEpiC	eye:	n/a
5	chr14:24476478-24476528	HMEC	breast:	n/a
6	chr14:24503311-24503361	ECC-1	luminal epithelium:	n/a
7	chr14:24505547-24505597	LNCaP	prostate:	n/a
8	chr14:24505653-24505703	SK-N-SH	brain:	n/a
9	chr14:24475906-24475956	IMR90	lung:	fetal
10	chr14:24476478-24476528	SKMC	muscle:	n/a
11	chr14:24505547-24505597	HCM	heart:	n/a
12	chr14:24505671-24505721	ProgFib	skin:	n/a
13	chr14:24505671-24505721	NHBE	bronchial:	n/a
14	chr14:24478620-24478670	HPAEpiC	pulmonary alveolar:	n/a
15	chr14:24476559-24476609	GM19239	blood:	n/a
16	chr14:24505554-24505604	Jurkat	blood:	n/a
17	chr14:24503311-24503361	HL-60	blood:	n/a
18	chr14:24476559-24476609	SK-N-SH_RA	brain:	n/a
19	chr14:24476478-24476528	HEEpiC	esophagus:	n/a
20	chr14:24476082-24476132	HCF	heart:	n/a
21	chr14:24478620-24478670	HRCEpiC	kidney:	n/a
22	chr14:24478620-24478670	NH-A	brain:	n/a
23	chr14:24476559-24476609	AoSMC	blood vessel:	n/a
24	chr14:24476559-24476609	CMK	blood:	n/a
25	chr14:24503311-24503361	GM12891	blood:	n/a
26	chr14:24476082-24476132	K562	blood:	n/a
27	chr14:24476478-24476528	HCPEpiC	choroid plexus:	n/a
28	chr14:24505554-24505604	HMEC	breast:	n/a
29	chr14:24476559-24476609	AG10803	skin:	n/a
30	chr14:24505537-24505587	AoSMC	blood vessel:	n/a
31	chr14:24478620-24478670	HEEpiC	esophagus:	n/a
32	chr14:24476559-24476609	SKMC	muscle:	n/a
33	chr14:24503311-24503361	GM06990	blood:	n/a
34	chr14:24476478-24476528	AG04450	lung:	fetal
35	chr14:24476559-24476609	GM12892	blood:	n/a
36	chr14:24476478-24476528	HRPEpiC	eye:	n/a
37	chr14:24505671-24505721	AG04449	skin:	fetal
38	chr14:24476082-24476132	HepG2	liver:	n/a
39	chr14:24505554-24505604	NH-A	brain:	n/a
40	chr14:24505653-24505703	PFSK-1	brain:	n/a
41	chr14:24505537-24505587	HepG2	liver:	n/a
42	chr14:24505537-24505587	PFSK-1	brain:	n/a
43	chr14:24476559-24476609	HRCEpiC	kidney:	n/a
44	chr14:24505537-24505587	HCF	heart:	n/a
45	chr14:24505537-24505587	MCF-7	breast:	n/a
46	chr14:24505537-24505587	NHDF-neo	bronchial:	n/a
47	chr14:24503311-24503361	K562	blood:	n/a
48	chr14:24476082-24476132	Hela-S3	cervix:	n/a
49	chr14:24476559-24476609	GM12878	blood:	n/a
50	chr14:24505537-24505587	SAEC	small airway:	n/a

No.	Distal block	Cell Line	Cell type
1	chr14:24482946..24483934-chr14:24503845..24504435,3	MCF-7	breast:
2	chr14:24482802..24483800-chr14:24505642..24506553,4	MCF-7	breast:
3	chr14:24482659..24484974-chr14:24503307..24504865,2	MCF-7	breast:
4	chr14:24482840..24483718-chr14:24710880..24711620,2	MCF-7	breast:
5	chr14:24483165..24483827-chr14:24559565..24560642,4	MCF-7	breast:
6	chr14:24476695..24479385-chr14:24563251..24564763,2	MCF-7	breast:
7	chr14:24483262..24483795-chr14:24906005..24906586,2	K562	blood:
8	chr14:24505359..24507247-chr14:24702110..24704400,2	MCF-7	breast:
9	chr14:24482946..24483934-chr14:24503845..24504435,3	MCF-7	breast:
10	chr14:24504090..24505966-chr14:24768791..24770568,2	MCF-7	breast:
11	chr14:24421533..24423333-chr14:24480435..24482151,2	K562	blood:
12	chr14:24505124..24506975-chr14:24520204..24522367,2	MCF-7	breast:
13	chr14:24482858..24483785-chr14:24559502..24560237,2	K562	blood:
14	chr14:24482659..24484974-chr14:24503307..24504865,2	MCF-7	breast:
15	chr14:24503791..24508058-chr14:24562194..24566408,5	MCF-7	breast:
16	chr14:24504490..24506127-chr14:24583788..24585514,2	MCF-7	breast:
17	chr14:24422701..24424551-chr14:24504249..24506129,2	MCF-7	breast:

Variant related genes	Relation type
ENSG00000225766	TF binding region
ENSG00000225766	CpG island
ENSG00000092330	chromatin interactions
ENSG00000157326	chromatin interactions
ENSG00000215256	chromatin interactions
ENSG00000100897	chromatin interactions
ENSG00000186648	chromatin interactions
ENSG00000196943	chromatin interactions
ENSG00000129535	chromatin interactions
ENSG00000157379	chromatin interactions
ENSG00000225766	chromatin interactions
ENSG00000100938	chromatin interactions
ENSG00000100889	chromatin interactions

Extended variants
information (count: 1276 )
Associated
traits (count: 62 )

Variant overlapped rSNPs/rCNVs (count:1276 , 50 per page) page: 1 2 3 4 5 6 7 ... 26

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs562345155	chr14:24475872-24475873	Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs575891314	chr14:24475873-24475874	Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs199503865	chr14:24475920-24475921	Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs541712049	chr14:24475923-24475924	Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs561880398	chr14:24475980-24475981	Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs200936205	chr14:24476042-24476043	Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs530084328	chr14:24476072-24476073	Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs540302989	chr14:24476074-24476075	Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs62000767	chr14:24476128-24476129	Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs560602096	chr14:24476138-24476139	Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs532676749	chr14:24476141-24476142	Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs552760264	chr14:24476142-24476143	Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs569485741	chr14:24476148-24476149	Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs531985382	chr14:24476242-24476243	Active TSS Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs548838676	chr14:24476251-24476252	Active TSS Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs533745947	chr14:24476269-24476270	Active TSS Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs553508456	chr14:24476270-24476271	Active TSS Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs531098508	chr14:24476271-24476272	Active TSS Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs539154761	chr14:24476325-24476326	Active TSS Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs555880908	chr14:24476328-24476329	Active TSS Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs575829412	chr14:24476329-24476330	Active TSS Flanking Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs148889809	chr14:24476433-24476434	Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs541651629	chr14:24476496-24476497	Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs555620208	chr14:24476544-24476545	Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs572266983	chr14:24476549-24476550	Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs189204581	chr14:24476574-24476575	Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs139008086	chr14:24476597-24476598	Flanking Active TSS Active TSS Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs532614016	chr14:24476662-24476663	Flanking Bivalent TSS/Enh Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs373978705	chr14:24476690-24476691	Flanking Bivalent TSS/Enh Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs546313106	chr14:24476693-24476694	Flanking Bivalent TSS/Enh Enhancers Weak transcription Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs574497935	chr14:24476695-24476696	Flanking Bivalent TSS/Enh Enhancers Weak transcription Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs543016696	chr14:24476696-24476697	Flanking Bivalent TSS/Enh Enhancers Weak transcription Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs181808290	chr14:24476714-24476715	Flanking Bivalent TSS/Enh Enhancers Weak transcription Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs140632978	chr14:24476720-24476721	Flanking Bivalent TSS/Enh Enhancers Weak transcription Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs150449310	chr14:24476722-24476723	Flanking Bivalent TSS/Enh Enhancers Weak transcription Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs4048587	chr14:24476732-24476733	Flanking Bivalent TSS/Enh Enhancers Weak transcription Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs528605778	chr14:24476741-24476742	Flanking Bivalent TSS/Enh Enhancers Weak transcription Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs527999501	chr14:24476767-24476768	Flanking Bivalent TSS/Enh Enhancers Weak transcription Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs547336997	chr14:24476795-24476796	Flanking Bivalent TSS/Enh Enhancers Weak transcription Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs546743368	chr14:24476826-24476827	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs570098932	chr14:24476830-24476831	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs539074365	chr14:24476867-24476868	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs377038525	chr14:24476902-24476903	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs555837958	chr14:24476903-24476904	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs185096484	chr14:24476932-24476933	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs375299918	chr14:24476935-24476936	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs536084023	chr14:24476965-24476966	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs535595124	chr14:24476972-24476973	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs368168952	chr14:24476979-24476980	Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs138282307	chr14:24477001-24477002	Weak transcription Enhancers Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:62)

Disease	PMID	Source
Cancer	20164920	CNVD
Esophageal cancer	21851588	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
High-proliferative meningiomas	17937814	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Non-small cell lung cancer	21044232	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Melanoma	18172304	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Medulloblastoma	21979893	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Breast cancer	17899364	CNVD
Colorectal cancer	16774939	CNVD
Neuroblastoma	19435921	CNVD
Colorectal cancer	19359472	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Lung cancer	16773561	CNVD
Multiple myeloma	16616336	CNVD
Cancer	17440070	CNVD
Breast cancer	16272173	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Epilepsy	20736978	CNVD
Mental retardation	20736978	CNVD
severe speech impairment	20736978	CNVD
speech impairment	20736978	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Lung cancer	18438408	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Renal cell carcinoma	21668985	CNVD
Prostate cancer	18632612	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Chronic myeloid leukemia	20724749	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21804112	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	17603634	CNVD
Esophageal cancer	20955586	CNVD
Cancer	21183584	CNVD
Leukoplakia	24403051	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Breast cancer	21364760	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Glioblastoma multiforme	21390271	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:648 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr14:24458800-24476000	Weak transcription	Fetal Intestine Small	intestine
2	chr14:24459200-24476000	Weak transcription	Liver	Liver
3	chr14:24472800-24476000	Weak transcription	Pancreas	Pancrea
4	chr14:24475000-24476000	Weak transcription	Primary B cells from cord blood	blood
5	chr14:24475200-24480000	Weak transcription	GM12878-XiMat	blood
6	chr14:24475400-24476200	Active TSS	iPS-20b Cell Line	embryonic stem cell
7	chr14:24475400-24476600	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
8	chr14:24475400-24476800	Active TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
9	chr14:24475600-24476600	Active TSS	Dnd41	blood
10	chr14:24475600-24482600	Weak transcription	Fetal Brain Male	brain
11	chr14:24475800-24476000	Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
12	chr14:24475800-24476000	Flanking Active TSS	Primary monocytes fromperipheralblood	blood
13	chr14:24475800-24476000	Flanking Active TSS	Primary B cells from peripheral blood	blood
14	chr14:24475800-24476000	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
15	chr14:24475800-24476000	Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
16	chr14:24475800-24476000	Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
17	chr14:24475800-24476000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
18	chr14:24475800-24476000	Flanking Active TSS	Fetal Muscle Leg	muscle
19	chr14:24475800-24476000	Active TSS	Skeletal Muscle Female	skeletal muscle
20	chr14:24475800-24476000	Flanking Active TSS	HepG2	liver
21	chr14:24475800-24476200	Flanking Active TSS	HUVEC	blood vessel
22	chr14:24475800-24476400	Active TSS	H1 Cell Line	embryonic stem cell
23	chr14:24475800-24476400	Active TSS	Primary neutrophils fromperipheralblood	blood
24	chr14:24475800-24476400	Active TSS	Primary T cells fromperipheralblood	blood
25	chr14:24475800-24476400	Active TSS	Colon Smooth Muscle	Colon
26	chr14:24475800-24476400	Active TSS	Fetal Adrenal Gland	Adrenal Gland
27	chr14:24475800-24476400	Active TSS	Fetal Thymus	thymus
28	chr14:24475800-24476600	Active TSS	H9 Cell Line	embryonic stem cell
29	chr14:24475800-24476600	Active TSS	Breast Myoepithelial Primary Cells	Breast
30	chr14:24475800-24476600	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
31	chr14:24475800-24476600	Active TSS	Brain Substantia Nigra	brain
32	chr14:24475800-24476600	Active TSS	Colonic Mucosa	Colon
33	chr14:24475800-24476600	Active TSS	Fetal Stomach	stomach
34	chr14:24475800-24476600	Active TSS	Ovary	ovary
35	chr14:24475800-24476600	Active TSS	Psoas Muscle	Psoas
36	chr14:24475800-24476600	Active TSS	Rectal Mucosa Donor 29	rectum
37	chr14:24475800-24476600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
38	chr14:24475800-24476600	Active TSS	NHEK	skin
39	chr14:24475800-24476800	Active TSS	iPS-15b Cell Line	embryonic stem cell
40	chr14:24475800-24476800	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
41	chr14:24475800-24476800	Active TSS	Primary T helper memory cells from peripheral blood 2	blood
42	chr14:24475800-24476800	Active TSS	Primary T helper cells PMA-I stimulated	--
43	chr14:24475800-24476800	Active TSS	Primary T helper 17 cells PMA-I stimulated	--
44	chr14:24475800-24476800	Active TSS	Primary T helper cells fromperipheralblood	blood
45	chr14:24475800-24476800	Flanking Active TSS	Primary Natural Killer cells fromperipheralblood	blood
46	chr14:24475800-24476800	Active TSS	Primary T killer naive cells fromperipheralblood	blood
47	chr14:24475800-24476800	Active TSS	Muscle Satellite Cultured Cells	--
48	chr14:24475800-24476800	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
49	chr14:24475800-24476800	Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
50	chr14:24475800-24476800	Active TSS	Foreskin Melanocyte Primary Cells skin01	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links